Israel - English - Ministry of Health

medison pharma ltd - doxorubicin hydrochloride - powder,dispersion and solvent for concentrate for dispersion for infusion - doxorubicin hydrochloride 50 mg vials - doxorubicin - doxorubicin - myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women.

Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - doxorubicin hydrochloride - injection - 2.00 mg/ml - doxorubicin hydrochloride 2.00 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - daunorubicin hydrochloride - powder for concentrate for solution for infusion - 20 milligram(s) - anthracyclines and related substances; daunorubicin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

galen ltd - daunorubicin hydrochloride citrate liposomal pegylated - solution for infusion - 2mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - capsule, hard - 10 milligram(s) - anthracyclines and related substances; idarubicin

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - capsule, hard - 5 milligram(s) - anthracyclines and related substances; idarubicin

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - idarubicin hydrochloride - solution for injection - 1 milligram(s)/millilitre - anthracyclines and related substances; idarubicin

Israel - English - Ministry of Health

novartis israel ltd - epirubicin hydrochloride - concentrate for solution for infusion - epirubicin hydrochloride 2 mg/ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of farmorubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after stransurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Israel - English - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - liposome concentrate for solution for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

Israel - English - Ministry of Health

novartis israel ltd - doxorubicin hydrochloride - solution for injection/ concentrate for solution for infusion - doxorubicin hydrochloride 2 mg/ml - doxorubicin - doxorubicin - soft tissue and bone sarcomas, hodgkin's and non-hodgkin's lymphoma, acute lymphoblastic leukemia, acute myeloblastic leukemia, wilms` tumor, carcinomas of the thyroid, breast, ovary, bladder, small cell bronchogenic carcinoma and neuroblastoma.